The Recall Desk
ModerateFDA (Drugs)·D-0197-2025·Announced 2025-01-22

Diphenhydramine HCl Capsules Recalled Due to Wrong Imprinting

Akron Pharma is recalling Diphenhydramine HCl 25 mg capsules nationwide because the capsules are imprinted with incorrect identification. Consumers should stop using the affected product.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This is an FDA Class III recall involving minor labeling errors (incorrect imprinting). No illnesses or injuries have been reported, making this a precautionary recall with a theoretical hazard.

Plain-English summary

Akron Pharma, Inc. is recalling Diphenhydramine HCl 25 mg capsules (100 capsules per bottle) due to incorrect imprinting on the capsules.

The capsules are imprinted with wrong identification markings.

The affected product includes Lot KDC0124001A with expiration date 09/30/2026, which was distributed nationwide in the United States. Approximately 7,198 bottles are affected.

Consumers who have purchased this product should stop using it immediately and consult with their healthcare provider or pharmacist for guidance on proper disposal or replacement.

The recalled product

Product
Diphenhydramine HCl 25 mg, 100 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8028-1.
Manufacturer
Akron Pharma, Inc.
Category
Drug
Hazard
  • mis-labeling

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot: KDC0124001A Exp 09/30/2026.

Distribution

Distributed nationwide across the United States.

Related recalls

Same category